Phenotypical Markers, Molecular Mutations, and Immune Microenvironment as Targets for New Treatments in Patients with Mycosis Fungoides and/or Sézary Syndrome.
Quaglino P, Fava P, Pileri A, Grandi V, Sanlorenzo M, Panasiti V, Guglielmo A, Alberti-Violetti S, Novelli M, Astrua C, Rubatto M, Tonella L, Berti E, Pimpinelli N, Osella Abate S, Fierro MT, Vermeer M, Scarisbrick JJ, Ribero S.
Quaglino P, et al. Among authors: tonella l.
J Invest Dermatol. 2021 Mar;141(3):484-495. doi: 10.1016/j.jid.2020.07.026. Epub 2020 Nov 5.
J Invest Dermatol. 2021.
PMID: 33162051
Free article.
Review.